AMBIA
BSX icon

Allen Mooney & Barnes Investment Advisors’s Boston Scientific BSX Stock Holding History

Allen Mooney & Barnes Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$342K Buy
7,824
+382
+5% +$17.7K 0.05% 122
2026
Q2 		$318K Buy
+7,442
New +$404K 0.05% 125

Other funds holding BSX

GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
PA
Persium Advisors Atlanta, Georgia $191M AUM 23.01% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Allen Mooney & Barnes Investment Advisors's BSX Position: Q3 2026 in Review

Allen Mooney & Barnes Investment Advisors increased its Boston Scientific (BSX) stake by 5.1% in Q3 2026, buying an estimated $17.7K and bringing the position to 7,824 shares worth $342K. The position accounts for 0.05% of the portfolio, ranked #122.

Allen Mooney & Barnes Investment Advisors first reported a position in BSX in Q2 2026 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Allen Mooney & Barnes Investment Advisors held 7,824 shares of Boston Scientific worth $342K as of Q3 2026.
  • Allen Mooney & Barnes Investment Advisors bought 382 Boston Scientific shares in Q3 2026, an estimated $17.7K.
  • Boston Scientific made up 0.05% of Allen Mooney & Barnes Investment Advisors's portfolio in Q3 2026, its #122 holding.
  • Allen Mooney & Barnes Investment Advisors first reported a position in Boston Scientific in Q2 2026 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.